Join
Live feed
·
INSIDERFilingvia Quantisnow
Tourmaline Bio Inc. logo

CEO Kulkarni Sandeep Chidambar returned 30,387 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TRML· Tourmaline Bio Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRML (Tourmaline Bio Inc.) and more on Quantisnow.